Dear Reader,
As we reach the final issue of Pediatric Drugs for 2018, we wish to reflect on another successful year’s achievements, and to thank all those who have contributed their time and effort to guarantee the high quality of our content.
2018 was a successful year for Pediatric Drugs. Over 50 articles have been published; the most popular of these, in terms of downloads from SpringerLink (up to the end of September), have been:
Saint GL, Semple MG, Sinha I, Hawcutt DB. Optimizing the Dosing of Intravenous Theophylline in Acute Severe Asthma in Children. Pediatr Drugs. 2018;20(3):209–214.
Ott MA, Crawley FP, Sáez-Llorens X, Owusu-Agyei S, Neubauer D, Dubin G, Poplazarova T, Begg N, Rosenthal SL. Ethical Considerations for the Participation of Children of Minor Parents in Clinical Trials. Pediatr Drugs. 2018;20(3):215–222.
Brusaferro A, Farinelli E, Zenzeri L, Cozzali R, Esposito S. The Management of Paediatric Functional Abdominal Pain Disorders: Latest Evidence. Pediatr Drugs. 2018;20(3):235–247.
Durgam S, Chen C, Migliore R, Prakash C, Edwards J, Findling RL. A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder. Pediatr Drugs. 2018;20(4):353–363.
Wang Y, Xu Y, Zou R, Wu L, Liu P, Yang H, Xie Z, Wang C. Effect of Levocarnitine on the Therapeutic Efficacy of Conventional Therapy in Children with Dilated Cardiomyopathy: Results of a Randomized Trial in 29 Children. Pediatr Drugs. 2018;20(3):285–290.
Wedekind MF, Denton NL, Chen CY, Cripe TP. Pediatric Cancer Immunotherapy: Opportunities and Challenges. Pediatr Drugs. 2018;20(5):395–408.
Kashiwagi T, Okada Y, Nomoto K. Palivizumab Prophylaxis Against Respiratory Syncytial Virus Infection in Children with Immunocompromised Conditions or Down Syndrome: A Multicenter, Post-Marketing Surveillance in Japan. Pediatr Drugs. 2018;20(1):97–104.
Stepanova E, Grant B, Findling RL. Asenapine Treatment in Pediatric Patients with Bipolar I Disorder or Schizophrenia: A Review. Pediatr Drugs. 2018;20(2):121–134.
Li A, Yeo K, Welty D, Rong H. Development of Guanfacine Extended-Release Dosing Strategies in Children and Adolescents with ADHD Using a Physiologically Based Pharmacokinetic Model to Predict Drug-Drug Interactions with Moderate CYP3A4 Inhibitors or Inducers. Pediatr Drugs. 2018;20(2):181–194.
van Rongen A, van der Aa MP, Matic M, van Schaik RHN, Deneer VHM, van der Vorst MM, Knibbe CAJ. Increased Metformin Clearance in Overweight and Obese Adolescents: A Pharmacokinetic Substudy of a Randomized Controlled Trial. Pediatr Drugs. 2018;20(4):365–374.
Social media sharing of information is becoming more important and is another metric with which to measure the reach of articles. This year the following articles published in Pediatric Drugs scored highly on the Altmetric system:
Puri L, Nottage KA, Hankins JS, Anghelescu DL. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease. Pediatr Drugs. 2018;20(1):29–42.
Tomlin AM, Woods DJ, Lloyd HS, Tilyard MW. Trends in Outpatient Prescription Medicine Use in New Zealand Children 2010-2015: A National Population-Based Study. Pediatr Drugs. 2018;20(5):465–474.
Durrieu G, Maupiler M, Rousseau V, Chebane L, Montastruc F, Bondon-Guitton E, Montastruc JL. Frequency and Nature of Adverse Drug Reactions Due to Non-Prescription Drugs in Children: A Retrospective Analysis from the French Pharmacovigilance Database. Pediatr Drugs. 2018;20(1):81–87.
Alqahtani S, Abouelkheir M, Alsultan A, Elsharawy Y, Alkoraishi A, Osman R, Mansy W. Optimizing Amikacin Dosage in Pediatrics Based on Population Pharmacokinetic/Pharmacodynamic Modeling. Pediatr Drugs. 2018;20(3):265–272.
Ott MA, Crawley FP, Sáez-Llorens X, Owusu-Agyei S, Neubauer D, Dubin G, Poplazarova T, Begg N, Rosenthal SL. Ethical Considerations for the Participation of Children of Minor Parents in Clinical Trials. Pediatr Drugs. 2018;20(3):215–222.
The quality of articles published in the journal is also reflected in its most recent impact factor. At 2.000, the impact of the journal remains high, and Pediatric Drugs is ranked 51 out of 124 pediatric journals.
We thank the authors who have contributed articles to Pediatric Drugs over the course of 2018. The skill and dedication of all authors are critical to the continued publication of the journal. The quality of published articles is also testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal’s content is held to the highest possible standard. We would like to thank the following individuals who acted as reviewers for Pediatric Drugs in the last 12 months:
Ahmed M. S. E. K. Abdelaty, UK
Ghanshyam D. Agarwal, USA
Karel Allegaert, Belgium
Jorge Amil Dias, Portugal
Peter Anderson, USA
Achilleas Attilakos, Greece
Hannah K. Batchelor, UK
Jules C. Beal, USA
David Q. Beversdorf, USA
Theresa Bingemann, USA
Sebastian Botzenhardt, Germany
Malcolm Brodie, UK
Peter Bulova, USA
Michael U. Callaghan, USA
Christina D. Chambers, USA
Naseem A. Charoo, United Arab Emirates
Olivier Chassany, France
Pratima Chowdary, UK
Joshua Courter, USA
Jean-Christophe Cuvellier, France
Steven J. Czinn, USA
Deonne Dersch-Mills, Canada
Geneviève Durrieu, France
Rhoikos Furtwängler, Germany
Luke Garratt, Australia
Roberta Giordano, Italy
Jennifer L. Goldman, USA
Suzanne Hagler, USA
Gillian C. Hall, UK
Benjamin Handen, USA
Philip Hazell, Australia
Pieter Hoekstra, the Netherlands
Stephen P. Hunger, USA
Alfonso Iorio, Canada
Lulu Jia, China
Kathrin Jobski, Germany
Gudmundur Johannsson, Sweden
Vivian Kafantaris, USA
Hyoung Jin Kang, Republic of Korea
Yusuf Cem Kaplan, Turkey
Vikram Kate, India
Robert M. Kennedy, USA
Carl Kirkwood, USA
Catherijne A. J. Knibbe, The Netherlands
Suresh Kotagal, USA
Eran Kozer, Israel
Jin-Won Kwon, Republic of Korea
Theodore Laetsch, USA
Lieven Lagae, Belgium
Cecilie Lander, Australia
Cecilie Johannessen Landmark, Norway
Maryse Lapeyre-Mestre, France
Sandra Le Quellec, France
Wojciech Leppert, Poland
Kevin Madden, USA
Akhil Maheshwari, USA
Johnny N. Mahlangu, South Africa
Christoph Male, Austria
David Mandelbaum, USA
Edoardo Marrani, Italy
Matthew T. McCarthy, USA
Francis F. Megraud, France
Maurizio Mennini, Italy
Jamie L. Miller, USA
Frederic Millot, France
Kirsten Minden, Germany
Adrian Miranda, USA
Kouji Miyazaki, Japan
Constance Monitto, USA
Hayat M. Mousa, USA
Elizabeth Mullen, USA
Kristen R. Nichols, USA
Yusuke Okubo, Japan
Courtney Olson-Chen, USA
Keliana O’Mara, USA
Monika Ostensen, Switzerland
Gayatri Palat, India
Yong-Ha Park, Republic of Korea
Suzanne Parker, Australia
Phillip L. Pearl, USA
Linny K. Phuong, Australia
Robert M. Post, USA
Colin V. Powell, UK
Samantha Jayne Prime, Australia
Markus Rauchenzauner, Germany
Amira S. E. Refay, Egypt
Claudio Romano, Italy
John M. Rosen, USA
Jesus Ruiz Ramos, Spain
Niharika Samala, USA
Regina Sawamura, Brazil
Valentina Shakhnovich, USA
Allan F. Simpao, USA
Brian G. Skotko, USA
P. Brian Smith, USA
Annamaria A. Staiano, Italy
Adam Sutherland, UK
Xuemei Tang, China
Jennifer Taylor-Cousar, USA
Catherine Tuleu, UK
Eva Untersmayr, Austria
Sven Christiaan van Dijkman, The Netherlands
Michiel P. van Wijk, The Netherlands
Suellen M. Walker, UK
Siri Wang, Norway
Adilia Warris, UK
Daniel W. Wheeler, UK
Sean Wilson, USA
Naomi Winick, USA
Cameron R. Wolfe, USA
Gaetano Zaccara, Italy
Nava Zisapel, Israel
In addition, we would like to thank the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:
Marina Aloi, Rome, Italy
John Berkenbosch, Louisville, KY, USA
Frank M. C. Besag, London, UK
Stan L. Block, Bardstown, KY, USA
Andrew Bush, London, UK
Rolando Cimaz, Florence, Italy
Saskia de Wildt, Rotterdam, The Netherlands
Brian Eley, Cape Town, South Africa
Susanna Esposito, Milan, Italy
Robert L. Findling, Baltimore, MD, USA
Dominic Fitzgerald, Westmead, Australia
Jennifer E. Girotto, Hartford, CT, USA
David A. Gremse, Mobile, AL, USA
Andreas H. Groll, Münster, Germany
Scott A. Halperin, Nova Scotia, Canada
Julian Hamilton-Shield, Bristol, UK
Gregory L. Holmes, Burlington, VT, USA
Gregory L. Kearns, Little Rock, AR, USA
Desiree Kunac, Dunedin, New Zealand
Stephen Lowis, Bristol, UK
Stuart M. MacLeod, Vancouver, Canada
Antje Neubert, Erlangen, Germany
Kathleen A. Neville, Little Rock, AR, USA
Terry Nolan, Parkville, Australia
Michael E. Pichichero, Rochester, NY, USA
Emmanuel Roilides, Thessaloniki, Greece
Catherine M. Sherwin, Salt Lake City, UT, USA
Robert Sidbury, Seattle, WA, USA,
William M. Splinter, Ottawa, Canada
John van den Anker, Washington, DC, USA
Diana A. van Riet-Nales, Utrecht, The Netherlands
Karen D. Wagner, Galveston, TX, USA
Hervé Walti, Paris, France
Ian C. Wong, London, UK
C Michel Zwaan, Rotterdam, The Netherlands
We do hope that you have found the articles published throughout the year in Pediatric Drugs to be interesting and informative. The editorial schedule for 2019 is well under way, and we are looking forward to bringing you many high-quality and authoritative articles over the coming year.
With best wishes, Rod McNab
Rights and permissions
About this article
Cite this article
Acknowledgement to Referees. Pediatr Drugs 20, 497–499 (2018). https://doi.org/10.1007/s40272-018-0317-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40272-018-0317-x